{7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack

RxCUI
1373503
RxNorm name
{7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack
Display name
Ethinyl estradiol/Levonorgestrel (Pack)
Full name
{7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack
Term type
GPCK
Status
Active
Strength
mixed
Dose form
Pack
Route
Pack
Updated
2026-11-16 14:57:01

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
052013
Active start
052013
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
ethinyl estradiol0.02 MG / 1 EACHethinyl estradiolethinyl estradiol
ethinyl estradiol0.025 MG / 1 EACHethinyl estradiolethinyl estradiol
ethinyl estradiol0.03 MG / 1 EACHethinyl estradiolethinyl estradiol
ethinyl estradiol0.01 MG / 1 EACHethinyl estradiolethinyl estradiol
levonorgestrel0.15 MG / 1 EACHlevonorgestrellevonorgestrel

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Pack746839

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
ethinyl estradiol4124
levonorgestrel6373

Source Vocabulary Codes#

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0378-7316-850378-7316LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL levonorgestrel and ethinyl estradiol and ethinyl estradiolMylan Pharmaceuticals Inc.ANDA206053

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA2060530378-7316LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL levonorgestrel and ethinyl estradiol and ethinyl estradiolANDAMylan Pharmaceuticals Inc.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00378731685rxnav_ndcsyes
51862048965rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RosyrahLEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOLXiromed, LLCd2f0af55-205f-df9c-c572-1f7b149766552025-11-10Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1373503
RivelsaLEVONORGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOLTeva Pharmaceuticals USA, Inc.822e56c6-562f-4299-bf4f-eaee0c0f2b7a2024-10-31Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1373503
LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOLLEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOLMylan Pharmaceuticals Inc.5c1d0a3a-1b24-44a0-9c53-224365b659452023-05-31Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 0378-7316-85
ndc (product): 0378-7316
ndc11 (package): 00378731685
rxcui: 1373503

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
822e56c6-562f-4299-bf4f-eaee0c0f2b7a{7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [GPCK] · Eth estra 0.01 MG (7) Oral Tablet / Eth estra-Levonorgest 0.02-0.15 MG (42) Oral Tablet / Eth estra-Levonorgest 0.025-0.15 MG (21) Oral Tablet / Eth estra-Levonorgest 0.03-0.15 MG (21) Oral Tablet 3 Month Pack [PSN]213These highlights do not include all the information needed to use RIVELSA safely and effectively. See full prescribing information for RIVELSA. RIVELSA ® (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 198220241022
5c1d0a3a-1b24-44a0-9c53-224365b65945{7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [GPCK] · Eth estra 0.01 MG (7) Oral Tablet / Eth estra-Levonorgest 0.02-0.15 MG (42) Oral Tablet / Eth estra-Levonorgest 0.025-0.15 MG (21) Oral Tablet / Eth estra-Levonorgest 0.03-0.15 MG (21) Oral Tablet 3 Month Pack [PSN]27These highlights do not include all the information needed to use LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS, AND ETHINYL ESTRADIOL TABLETS, safely and effectively. See full prescribing information for LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS, AND ETHINYL ESTRADIOL TABLETS. LEVONORGESTREL and ETHINYL ESTRADIOL tablets, and ETHINYL ESTRADIOL tablets, for oral use Initial U.S. Approval: 198220230531
d2f0af55-205f-df9c-c572-1f7b14976655{7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [GPCK] · Eth estra 0.01 MG (7) Oral Tablet / Eth estra-Levonorgest 0.02-0.15 MG (42) Oral Tablet / Eth estra-Levonorgest 0.025-0.15 MG (21) Oral Tablet / Eth estra-Levonorgest 0.03-0.15 MG (21) Oral Tablet 3 Month Pack [PSN]22These highlights do not include all the information needed to use ROSYRAH, safely and effectively. See full prescribing information for ROSYRAH. ROSYRAH, for oral use Initial U.S. Approval: 198220251110

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
5c1d0a3a-1b24-44a0-9c53-224365b65945These highlights do not include all the information needed to use LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS, AND ETHINYL ESTRADIOL TABLETS, safely and effectively. See full prescribing information for LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS, AND ETHINYL ESTRADIOL TABLETS. LEVONORGESTREL and ETHINYL ESTRADIOL tablets, and ETHINYL ESTRADIOL tablets, for oral use Initial U.S. Approval: 1982Mylan Pharmaceuticals Inc.20230531
4d3d8398-84cc-4336-9e77-ac15925d1605These highlights do not include all the information needed to use LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS AND ETHINYL ESTRADIOL TABLETS. LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS AND ETHINYL ESTRADIOL TABLETS, for oral use Initial U.S. Approval: 1982Mayne Pharma Inc. | Teva Pharmaceuticals USA, Inc.20181113

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCG03ADEmergency contraceptivesATC1-4levonorgestrel
ATCL02AAEstrogensATC1-4ethinyl estradiol
ATCG03CANatural and semisynthetic estrogens, plainATC1-4ethinyl estradiol
ATCG03ACProgestogensATC1-4levonorgestrel
ATCG03AAProgestogens and estrogens, fixed combinationsATC1-4ethinyl estradiol / levonorgestrel
ATCG03ABProgestogens and estrogens, sequential preparationsATC1-4ethinyl estradiol / levonorgestrel
FDASPLD045167Progesterone CongenersCHEMhas_chemical_structurelevonorgestrel
FDASPLN0000175825EstrogenEPChas_epcethinyl estradiol
FDASPLN0000175602ProgestinEPChas_epclevonorgestrel
FDASPLN0000175832Progestin-containing Intrauterine SystemEPChas_epclevonorgestrel
FDASPLN0000000100Estrogen Receptor AgonistsMOAhas_moaethinyl estradiol
FDASPLN0000175830Inhibit Ovum FertilizationPEhas_pelevonorgestrel
MEDRTD004997Ethinyl EstradiolCHEMhas_ingredientethinyl estradiol
MEDRTD016912LevonorgestrelCHEMhas_ingredientlevonorgestrel
MEDRTD000022Abortion, SpontaneousDISEASEinduceslevonorgestrel
MEDRTD018248Adenoma, Liver CellDISEASEci_withlevonorgestrel
MEDRTD001943Breast NeoplasmsDISEASEci_withethinyl estradiol
MEDRTD001943Breast NeoplasmsDISEASEmay_treatethinyl estradiol
MEDRTD001943Breast NeoplasmsDISEASEci_withlevonorgestrel
MEDRTD002539Cerebral Arterial DiseasesDISEASEci_withethinyl estradiol
MEDRTD002561Cerebrovascular DisordersDISEASEci_withlevonorgestrel
MEDRTD003324Coronary Artery DiseaseDISEASEci_withethinyl estradiol
MEDRTD003327Coronary DiseaseDISEASEci_withlevonorgestrel
MEDRTD003920Diabetes MellitusDISEASEci_withlevonorgestrel
MEDRTD004342Drug HypersensitivityDISEASEci_withethinyl estradiol
MEDRTD004342Drug HypersensitivityDISEASEci_withlevonorgestrel
MEDRTD016889Endometrial NeoplasmsDISEASEci_withethinyl estradiol
MEDRTD016889Endometrial NeoplasmsDISEASEci_withlevonorgestrel
MEDRTD020773Headache DisordersDISEASEci_withlevonorgestrel
MEDRTD006349Heart Valve DiseasesDISEASEci_withlevonorgestrel
MEDRTD019584Hot FlashesDISEASEmay_treatethinyl estradiol
MEDRTD006973HypertensionDISEASEci_withlevonorgestrel
MEDRTD006973HypertensionDISEASEci_withethinyl estradiol
MEDRTD007006HypogonadismDISEASEmay_treatethinyl estradiol
MEDRTD007565JaundiceDISEASEci_withlevonorgestrel
MEDRTD007674Kidney DiseasesDISEASEci_withlevonorgestrel
MEDRTD008107Liver DiseasesDISEASEci_withethinyl estradiol
MEDRTD008107Liver DiseasesDISEASEci_withlevonorgestrel
MEDRTD008113Liver NeoplasmsDISEASEci_withlevonorgestrel
MEDRTD008594Menopause, PrematureDISEASEmay_treatethinyl estradiol
MEDRTD008595MenorrhagiaDISEASEmay_treatethinyl estradiol
MEDRTD009376Neoplasms, Hormone-DependentDISEASEci_withethinyl estradiol
MEDRTD015663Osteoporosis, PostmenopausalDISEASEmay_preventethinyl estradiol
MEDRTD011247PregnancyDISEASEmay_preventethinyl estradiol
MEDRTD011247PregnancyDISEASEmay_preventlevonorgestrel
MEDRTD011247PregnancyDISEASEci_withlevonorgestrel
MEDRTD011247PregnancyDISEASEci_withethinyl estradiol
MEDRTD016649Primary Ovarian InsufficiencyDISEASEmay_treatethinyl estradiol
MEDRTD011471Prostatic NeoplasmsDISEASEmay_treatethinyl estradiol
MEDRTD013923ThromboembolismDISEASEci_withlevonorgestrel
MEDRTD013923ThromboembolismDISEASEci_withethinyl estradiol
MEDRTD013924ThrombophlebitisDISEASEci_withethinyl estradiol
MEDRTD013924ThrombophlebitisDISEASEci_withlevonorgestrel
MEDRTD064424Tobacco UseDISEASEci_withethinyl estradiol
MEDRTD014029Tobacco Use DisorderDISEASEci_withlevonorgestrel
MEDRTD014592Uterine HemorrhageDISEASEci_withlevonorgestrel
MEDRTN0000000100Estrogen Receptor AgonistsMOAhas_moaethinyl estradiol
MEDRTN0000000185Progestational Hormone Receptor AgonistsMOAhas_moalevonorgestrel
MEDRTN0000008311Bone Formation StimulationPEhas_peethinyl estradiol
MEDRTN0000008595Decreased Embryonic ImplantationPEhas_peethinyl estradiol
MEDRTN0000008595Decreased Embryonic ImplantationPEhas_pelevonorgestrel
MEDRTN0000009072Hypothalamic Endocrine Activity AlterationPEhas_pelevonorgestrel
MEDRTN0000178478Increased Blood PressurePEci_pelevonorgestrel
MEDRTN0000009717Inhibit OvulationPEhas_peethinyl estradiol
MEDRTN0000009717Inhibit OvulationPEhas_pelevonorgestrel
MEDRTN0000009902Vaginal Function AlterationPEhas_peethinyl estradiol
MEDRTN0000008289Aromatic hydroxylationPKhas_pkethinyl estradiol
MEDRTN0000000045Fecal ExcretionPKhas_pkethinyl estradiol
MEDRTN0000000026Hepatic MetabolismPKhas_pkethinyl estradiol
MEDRTN0000000042Renal ExcretionPKhas_pkethinyl estradiol

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA206053
CODESVUID4042108
NAMESPrescribable SynonymEth estra 0.01 MG (7) Oral Tablet / Eth estra-Levonorgest 0.02-0.15 MG (42) Oral Tablet / Eth estra-Levonorgest 0.025-0.15 MG (21) Oral Tablet / Eth estra-Levonorgest 0.03-0.15 MG (21) Oral Tablet 3 Month Pack
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary